Variability in clinical features of early versus late cardiovascular implantable electronic device pocket infections

PACE - Pacing and Clinical Electrophysiology

Volumn 37, Issue 8, 2014, Pages 955-962

  Welch, Mariko ^a   Uslan, Daniel Z ^b   Greenspon, Arnold J ^c   Sohail, Muhammad R ^d   Baddour, Larry M ^d   Blank, Elisabeth ^e   Carrillo, Roger G ^f   Danik, Stephan B ^g   Del Rio, Ana ^h   Hellinger, Walter ⁱ   Le, Katherine Y ^d   Miro, Jose M ^h   Naber, Christoph ^e   Peacock, James E ^j   Vikram, Holenarasipur R ^k   Tseng, Chi Hong ^b   Prutkin, Jordan M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^d MAYO CLINIC   (United States)

^e ELISABETH KRANKENHAUS ESSEN   (Germany)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h UNIVERSITY OF BARCELONA   (Spain)

ⁱ MAYO CLINIC   (United States)

^j WAKE FOREST SCHOOL OF MEDICINE   (United States)

^k MAYO CLINIC   (United States)

more..

Author keywords

cardiac implantable devices; device infection; endocarditis

Indexed keywords

ADVERSE EFFECTS; AGED; ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MALE; MULTICENTER STUDY; PROSPECTIVE STUDY; PROSTHESIS-RELATED INFECTIONS; TIME;

AGED; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; PACEMAKER, ARTIFICIAL; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS; TIME FACTORS;

EID: 84905966393     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12385     Document Type: Article

References (33)

1. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm 2008; 5: e1-e62.
2. Birnie K, Williams A, Guo A, Mielniczuk L, Davis D, Lemery R, Green M, et al. Reasons for escalating pacemaker implants. Am J Cardiol 2006; 98: 93-97.
3. Goldberger Z, Lampert R,. Implantable cardioverter-defibrillators: Expanding indications and technologies. J Am Med Assoc 2006; 295: 809-818.
4. Zhan C, Baine WB, Sedrakyan A, Steiner C., Cardiac device implantation in the United States from 1997 through 2004: A population-based analysis. J Gen Intern Med 2008; 23 (Suppl 1): 13-19.
5. Uslan DZ, Tleyjeh IM, Baddour LM, Friedman PA, Jenkins SM, St Sauver JL, Hayes DL,. Temporal trends in permanent pacemaker implantation: A population based study. Am Heart J 2008; 155: 896-903.
6. Cabell CH, Heidenreich PA, Chu VH, Moore CM, Stryjewski ME, Corey GR, Fowler VG Jr., Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J 2004; 147: 582-586.
7. Voigt A, Shalaby A, Saba A,. Continued rise in rates of cardiovascular implantable device infection in the United States: Temporal trends and causative insights. Pacing Clin Electrophysiol 2010; 33: 414-419.
8. Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, Pavri BB, et al. Sixteen year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States: 1993-2008. J Am Coll Cardiol 2011; 55: 1001-1006.
9. Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, Culler SD, Simon AW,. The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol 2006; 47: 2493-2497.
10. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, Masoudi FA, et al. Update on cardiovascular implantable electronic device infections and their management. A scientific statement from the American Heart Association. Circulation 2010; 121: 458-477.
11. Voigt A, Shalaby A, Saba S,. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol 2006; 48: 590-591.
12. Johansen JB, Nielsen JC, Arnsbo P, Moller M, Pedersen AK, Mortensen PT,. Higher incidence of pacemaker infection after replacement than after first implantation: Experiences from 36,076 consecutive patients. Heart Rhythm 2006; 3 (Suppl 1): S102-S103.
13. Kay GN, Brinker JA, Kawanishi DT, Love CJ, Lloyd MA, Reeves RC, Pioger G, et al. Risks of spontaneous injury and extraction of an active fixation pacemaker lead: Report of the Accufix Multicenter Clinical Study and Worldwide Registry. Circulation 1999; 100: 2344-2352.
14. Wade JS, Cobbs CG,. Infections in cardiac pacemakers. Curr Clin Top Inf Dis 1988; 9: 44-61.
15. Sohail SR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007; 49: 1851-1859.
16. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, et al. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis 2007; 45: 166-173.
17. Bloom H, Heeke B, Leon A, Mera F, Delurgio D, Beshai J, Langberg J,. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol 2006; 29: 142-145.
18. Lekkerkerker JC, van Nieuwkoop C, Trines SA, van der Bom JG, Bernards A, van de Velde ET, Bootsma M, et al. Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart 2009; 95: 715-720.
19. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633-638.
20. Charlson ME, Pompei P, Ales K, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40: 373-383.
21. Wilkoff BL, Love CJ, Byrd CL, Bongiorni MG, Carrillo RG, Crossley GH 3rd, Epstein LM, et al. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management. Heart Rhythm 2009; 6: 1085-1104.
22. Greenspon AJ, Prutkin JM, Mohammad RS, Vikram HR, Baddour LM, Danik SB, Peacock J, et al. Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis: Results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort). J Am Coll Cardiol 2012; 59: 681-687.
23. Da CA, Lelievre H, Kirkorian G, Célard M, Chevalier P, Vandenesch F, Etienne J, et al. Role of the preaxillary flora in pacemaker infections: A prospective study. Circulation 1998; 97: 1791-1795.
24. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM,. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000; 133: 604-608.
25. Golzio PG, Fanelli AL, Vinci M, Pelissero E, Morello M, Marra WF, Gaita F,. Lead vegetations in patients with local and systemic cardiac device infections: Prevalence, risk factors, and therapeutic effects. Europace 2013; 15: 89-100.
26. Tarakji KG, Chan EJ, Cantillon DJ, Doonan AL, Hu T, Schmitt S, Fraser TG, et al. Cardiac implantable electronic device infections: Presentation, management, and patient outcomes. Heart Rhythm 2010; 7: 1043-1047.
27. Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R, Gottipaty V, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: Results from the REPLACE registry. Circulation 2010; 122: 1553-1561.
28. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, Rey JL, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: Results of a large prospective study. Circulation 2007; 116: 1349-1355.
29. Kutinsky, Jarandilla R, Jewett M, Haines DE,. Risk of hematoma complications after device implant in the clopidogrel era. Circ Arrhythm Electrophysiol 2010; 3: 312-318.
30. Sohail MR, Hussain S, Le KY, Dib C, Lohse CM, Friedman PA, Hayes DL, et al. Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections. J Interv Card Electrophysiol 2011; 31: 171-183.
31. Johansen JB, Jorgensen OD, Moller M, Arnsbo P, Mortensen PT, Nielsen JC,. Infection after pacemaker implantation: Infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J 2011; 32: 991-998.
32. Catanchin A, Murdock CJ, Athan E,. Pacemaker infections: A 10-year experience. Heart Lung Circ 2007; 16: 434-439.
33. Viola GM, Awan LL, Darouiche RO,. Nonstaphylococcal infections of cardiac implantable electronic devices. Circulation 2010; 19: 2085-2091.